{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:14:47Z","timestamp":1787015687515,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":3474,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1111\/jth.12257","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:19:35Z","timestamp":1372637975000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S1","title":["Translational medicine advances in von Willebrand disease"],"prefix":"10.1016","volume":"11","author":[{"given":"D.","family":"Lillicrap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12257_bb0010","first-page":"87","article-title":"Hereditar pseudohemofili","volume":"LXVII","author":"von Willebrand","year":"1926","journal-title":"Finska Lakaresallskapets Handlingar"},{"key":"10.1111\/jth.12257_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0954-6820.1957.tb00123.x","article-title":"von Willebrand's disease and its correction with human plasma fraction 1\u20130","volume":"159","author":"Nilsson","year":"1957","journal-title":"Acta Medica Scandinavica"},{"key":"10.1111\/jth.12257_bb0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI106480","article-title":"Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's disease, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against anti","volume":"50","author":"Zimmerman","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12257_bb0025","first-page":"152","article-title":"Determination of the von Willebrand's disease antigen (factor VIII\u2010related antigen) in plasma by quantitative immunoelectrophoresis","volume":"86","author":"Zimmerman","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.12257_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJM197407182910301","article-title":"Inherited variants of factor\u2010VIII\u2010related protein in von Willebrand's disease","volume":"291","author":"Peake","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12257_bb0035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"von Willebrand factor and von Willebrand disease","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0040","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12257_bb0045","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"key":"10.1111\/jth.12257_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"key":"10.1111\/jth.12257_bb0055","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1093\/nar\/13.13.4699","article-title":"Construction of cDNA coding for human von Willebrand factor using antibody probes for colony\u2010screening and mapping of the chromosomal gene","volume":"13","author":"Verweij","year":"1985","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/jth.12257_bb0060","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12257_bb0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"key":"10.1111\/jth.12257_bb0070","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry"},{"key":"10.1111\/jth.12257_bb0075","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI109070","article-title":"von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease","volume":"61","author":"Montgomery","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12257_bb0080","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1538-7836.2003.00260.x","article-title":"von Willebrand factor, platelets and endothelial cell interactions","volume":"1","author":"Ruggeri","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0085","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood.V87.6.2292.bloodjournal8762292","article-title":"Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C","volume":"87","author":"Koppelman","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0095","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0021-9258(18)32879-5","article-title":"Biosynthesis of von Willebrand protein by human endothelial cells: identification of a large precursor polypeptide chain","volume":"258","author":"Wagner","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12257_bb0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI112064","article-title":"Biosynthesis of von Willebrand protein by human megakaryocytes","volume":"76","author":"Sporn","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12257_bb0105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1074\/jbc.M508316200","article-title":"ADAMTS13 substrate recognition of von Willebrand factor A2 domain","volume":"281","author":"Zanardelli","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12257_bb0110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor","volume":"324","author":"Zhang","year":"2009","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1111\/jth.12257_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2516.2011.02558.x","article-title":"Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres","volume":"17","author":"Byams","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12257_bb0120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.2004.00176.x","article-title":"von Willebrand disease in women with menorrhagia: a systematic review","volume":"111","author":"Shankar","year":"2004","journal-title":"BJOG"},{"key":"10.1111\/jth.12257_bb0125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand's disease: variability versus \u201cvariants\u201d","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0130","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM\u20101VWD)","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/jth.12257_bb0145","first-page":"187","article-title":"Prenatal diagnosis of von Willebrand disease in a family","volume":"18","author":"Trasi","year":"2008","journal-title":"Natl Med J India"},{"key":"10.1111\/jth.12257_bb0150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-2516.2008.01813.x","article-title":"The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network","volume":"14","author":"Keeney","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12257_bb0155","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletions correlate with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton\u2010Inloes","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12257_bb0160","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1073\/pnas.85.8.2753","article-title":"Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease","volume":"85","author":"Ngo","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12257_bb0165","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand Disease","author":"James","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/jth.12257_bb0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2516.2008.01682.x","article-title":"Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease","volume":"14","author":"Baronciani","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12257_bb0180","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12257_bb0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian Type 3 von Willebrand disease (VWD): further evidence for co\u2010dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12257_bb0195","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.12257_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12257_bb0205","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2006-947870","article-title":"Genetic testing for von Willebrand disease: the Canadian experience","volume":"32","author":"James","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12257_bb0210","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12257_bb0215","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS\u201013 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0220","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-2007-1000368","article-title":"Platelet\u2010type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes","volume":"33","author":"Othman","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12257_bb0225","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0230","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0235","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.1074\/jbc.M006548200","article-title":"Identification of the collagen\u2010binding site of the von Willebrand factor A3\u2010domain","volume":"276","author":"Romijn","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12257_bb0240","first-page":"398","article-title":"Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen","volume":"13","author":"Denis","year":"1993","journal-title":"Art Thromb Vasc Biol"},{"key":"10.1111\/jth.12257_bb0245","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1538-7836.2012.04746.x","article-title":"Critical von Willebrand factor A1 domain residues influence type VI collagen binding","volume":"10","author":"Flood","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0250","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0037-1616142","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0255","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2008-10-184317","article-title":"Characterisation of W1745C and S1783A, two novel collagen binding defects in the A3 domain of von Willebrand factor","volume":"114","author":"Riddell","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0260","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0265","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1538-7836.2012.04747.x","article-title":"Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease","volume":"10","author":"Flood","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0270","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding assay: 21\u00a0years of age and beyond adolescence but not yet a mature adult","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12257_bb0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0029-1214149","article-title":"Toward a new paradigm for the identification and functional characterization of von Willebrand disease","volume":"35","author":"Favaloro","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12257_bb0280","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0038-1648458","article-title":"von Willebrand disease masquerading as haemophilia A","volume":"67","author":"Mazurier","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0285","first-page":"350","article-title":"Type 2N von Willebrand disease","volume":"4","author":"Mazurier","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1111\/jth.12257_bb0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-2143(97)90019-6","article-title":"von Willebrand disease and quantitative variation in von Willebrand factor","volume":"130","author":"Mohlke","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.12257_bb0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0305","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0310","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"von Willebrand factor mutations and new sequence variations identified in healthy controls are more frequent in the African\u2010American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jth.12093","article-title":"Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes","volume":"11","author":"Wang","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1538-7836.2009.03482.x","article-title":"Genetic testing for von Willebrand disease: the case against","volume":"8","author":"Favaloro","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1538-7836.2009.03670.x","article-title":"Genetic testing for von Willebrand disease: the case for","volume":"8","author":"Peake","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0330","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0335","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM\u20101VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0340","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM\u20101VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0345","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2013from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12257_bb0350","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1538-7836.2007.02410.x","article-title":"Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment","volume":"5","author":"Pierce","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12257_bb0355","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0360","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel\u2010releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG"},{"key":"10.1111\/jth.12257_bb0365","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0030-1255445","article-title":"Structure and function of a recombinant von Willebrand factor drug candidate","volume":"36","author":"Turecek","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12257_bb0370","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.237.237","article-title":"Recombinant human von Willebrand factor (rhVWF): first in\u2010human study evaluating pharmacokinetics, demonstrating safety and tolerability in type 3 von Willebrand disease","volume":"116","author":"Suiter","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0375","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1182\/blood-2011-09-382846","article-title":"Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients","volume":"119","author":"Powell","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0380","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"von Willebrand factor to the rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0385","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1182\/blood-2005-09-3605","article-title":"Phenotypic correction of von Willebrand disease type 3 blood\u2010derived endothelial cells with lentiviral vectors expressing von Willebrand factor","volume":"107","author":"De Meyer","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0390","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2005-06-2330","article-title":"Correction of a murine model of von Willebrand disease by gene transfer","volume":"108","author":"Pergolizzi","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12257_bb0395","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/jth.12008","article-title":"von Willebrand factor: the old, the new and the unknown","volume":"10","author":"Lenting","year":"2012","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12257","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12257","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622051492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622051492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12257\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:04:00Z","timestamp":1761534240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622051492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":78,"alternative-id":["S1538783622051492"],"URL":"https:\/\/doi.org\/10.1111\/jth.12257","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational medicine advances in von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}